MD

Mike Dybbs

at Samsara BioCapital

Burlingame, California

Invests in

Stages:

Sectors:

San Francisco Bay Area

Locations:

San Francisco, California

Palo Alto, California

Min Investment:
$10,000,000.00
Max Investment:
$100,000,000.00
Target Investment:
$25,000,000.00

Education

PhD
University of California, Berkeley
(1999 - 2005)
AB
Harvard University
(1993 - 1997)

Lists including Mike

All Series A Investors

14752 people

All Seed Investors

19695 people

Investments

Arcellx

Total Funding: $120M

Ionpath

Total Funding: $18M

Nkarta Therapeutics

Total Funding: $110M

Sutro Biopharma

Total Funding: $110M

Principia Biopharma

Total Funding: $78M

Advanced Cell Diagnostics

Total Funding: $34M

Dimension Therapeutics

Total Funding: $65M

Versartis

Total Funding: $130M

Work Experience

Samsara BioCapital

2017

Partner
2017

Dimension Therapeutics

2015 - 2017

Board of Directors
2015 - 2017

Principia Biopharma

2014 - 2016

Board of Directors
2014 - 2016

Advanced Cell Diagnostics

2012 - 2016

Board of Directors
2012 - 2016

New Leaf Venture Partners

2009 - 2016

Partner
2009 - 2016

Versartis, Inc.

2013 - 2014

Board of Directors
2013 - 2014

The Boston Consulting Group

2005 - 2009

Principal
2005 - 2009